Disc Medicine names new director and new general counsel
5 January 2022 -

Disc Medicine, a US-based clinical-stage biopharmaceutical company, announced on Tuesday that it has named Jay T Backstrom, MD., MP as its director and Rahul Khara, Pharm.D., JD, as its general counsel.

Dr Backstrom has served executive vice president, head of Research and Development at Acceleron Pharma. He has more than 30 years of experience in research and development and was previously chief medical officer (and head of Regulatory Affairs) at Celgene. He has held the position of vice president of Global Medical Affairs and Safety at Pharmion. He started his career at Marion Merrell Dow and continued as part of its successor companies including Hoechst Marion Roussel. He has also held the position of staff physician and medical director of the Samuel U. Rodgers Community Health Center in Kansas City, Missouri.

Dr Khara has held the position of vice president, Legal and chief compliance officer at Acceleron Pharma. He has served at the law firms of Arnold & Porter LLP and Sidley Austin LLP, working with biopharma companies in various stages of development to navigate legal issues related to the clinical development of new assets, launch of new drug products, business development transactions, compliance, and enforcement.